Author Page for Dr. Zafar Iqbal

Employing Integrated Omics, Artificial Intelligence and Machine learning Tools for Refined Stratification of Blast Crisis CML Patients via Genetic clustering and COSMIC Mutational Signatures: A Practical Framework for Precision Repurposing of FDA/EMA-Approved Anti-Cancer Drugs in Refractory Cancers post-COVID19

No

Number of pages: 15 Posted: 24 Jul 2025

Dr Abdulkareem Algarni MD, Nawaf Alanzazi, Sarah AlMukhaylid, Sultan Al Qahtani, Hassan Almasoudi, Yaqob Taleb, Nada Alkhamis, Amer Mahmood, Tayyib Hussain, Sameerah Shaheen, Abdulaziz Siyal, Aamer Aleem, Riazul Haq, Rizwan Naeem, Masood Shammas, Giuseppe Saglio, Norah Algarzae, Deema Alroweilly and Dr. Zafar Iqbal

King Abdulaziz Hospital, King Abdulaziz Hospital, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Hospital, Najran University, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, King Saud University - Cancer Stem Cell Group, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, King Saud University, Riyadh, Saudia Arabia, King Saud University - Cancer Stem Cell Group, King Saud University Medical City, University of Texas Health Science Center at San Antonio, Albert Einstein College of Medicine, Department of Medical Oncology, Harvard (Dana Farber) Cancer Institute, University of Turin, King Saud University, Riyadh, Saudia Arabia, King Saud University, Riyadh, Saudia Arabia and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs

Downloads 124 (584,619)

Abstract:

2.

Investigations on drug targetable gene mutations in blast crisis chronic myeloid leukemia and their possible implication in drug repurposing for drug-resistant advanced phase CML

Number of pages: 15 Posted: 09 May 2024

Nawaf Alanzazi, Batool Salman Alnajad, Fatima Alali, Anwar Al-rasasi, Kanza, Sahar Al-hakeem, Sarah Al-Mukhaylid and Dr. Zafar Iqbal

King Abdulaziz Hospital, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs

Downloads 116 (626,371)

Abstract:

3.

Rare Pediatric Hematological and Non-hematological Diseases in Saudi Arabia: A Systematic Review and Meta-Analysis

Number of pages: 19 Posted: 16 Jun 2025

Nawaf Alanzazi, Sarah Al-Mukhaylid and Dr. Zafar Iqbal

King Abdulaziz Hospital, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs

Downloads 93 (759,537)

Abstract:

4.

Yaqob Taleb. An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID-19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management Strategies

This article has been peer-reviewed and published at https://www.fortunejournals.com/articles/an-indepth-insight-into-clinical-cellular-and-molecular-factors-in-covid19associated-cardiovascular-ailments-for-identifying-novel.html. It’s indexed in Europe PMC (PubMed central) as well (https://europepmc.org/article/PPR/PPR742858 ).

Number of pages: 19 Posted: 17 Oct 2023 Last Revised: 07 Dec 2024

Muneera Altaweel, Abdulmohsen AlMusaad, Gousay Alkhazmari, Hussain Alrowaily, Maram AlSubaiee, Mareyah Alshaikh Husain, Nouf Alomayrin, Rafyel Al muaiweed, Norah Aleid, Abdulrahman A Alarfaj, Sarah AlMukhaylid, Zainab Albahrani, Aftab Ahmed Jalbani and Dr. Zafar Iqbal

Ministry of Health (Saudi Arabia), King Abdullah International Medical Research Center, Imam Abdulrahman Al Faisal Hospital, Northern Border University, Ministry of Health (Saudi Arabia), King Abdulaziz Hospital, King Faisal University (KFU), King Faisal University (KFU), Ministry of Health (Saudi Arabia), King Saud Bin Abdulaziz University for Health Sciences, King Saud Bin Abdulaziz University for Health Sciences, Ministry of Health (Saudi Arabia), Ministry of Health (Saudi Arabia) and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs

Downloads 75 (852,604)

Citation 1

Abstract:

5.

Metabolic and Nutritional Mutation Signatures Drive Early Progression of Chronic Myeloid Leukemia: A Whole-Exome and AI-Guided Precision Framework

No

Number of pages: 22 Posted: 29 Jul 2025

Dr. Zafar Iqbal, Sarah AlMukhaylid, Masood Shammas, Sultan Al Qahtani, Dr Abdulkareem Algarni MD, Aamer Aleem, Nawaf Alanzazi, Yaqob Taleb, Rizwan Naeem, Amer Mahmood and Giuseppe Saglio

King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, Department of Medical Oncology, Harvard (Dana Farber) Cancer Institute, King Abdulaziz Hospital, King Abdulaziz Hospital, King Saud University Medical City, King Abdulaziz Hospital, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Albert Einstein College of Medicine, King Saud University - Cancer Stem Cell Group and University of Turin

Downloads 63 (989,921)

Abstract:

6.

Utilization of targeted resequencing for clinical validation of mutated FANCD2 gene as a promising molecular biomarker of early disease progression in Saudi Chronic Myeloid Leukemia: A case-control study

Number of pages: 20 Posted: 19 Dec 2023 Last Revised: 07 Mar 2024

Nawaf Alanzazi, Abdulaziz Siyal, Salman Basit, Masood Shammas, Amer Mahmood, Sarah AlMukhaylid and Dr. Zafar Iqbal

King Abdulaziz Hospital, King Saud University - Cancer Stem Cell Group, Center for Genetics and Inherited Diseases, Taibah University Madinah., Department of Medical Oncology, Harvard (Dana Farber) Cancer Institute, King Saud University - Cancer Stem Cell Group, King Saud Bin Abdulaziz University for Health Sciences and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs

Downloads 59 (989,921)

Abstract:

7.

Investigations on Comparative Effectiveness of Online Teaching for Delivery of Typical Health Sciences Program Curriculum, In Relation to Intended Learning Outcomes and Student Satisfaction

Number of pages: 13 Posted: 14 May 2024

Nawaf Alanzazi, Joawher Alshouish, Kawthar Alsaeed, Zahra Alali, Kanza, Muhammad Khalid Mehmood Sajid, Sarah Al-Mukhaylid and Dr. Zafar Iqbal

King Abdulaziz Hospital, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs

Downloads 47 (1,097,529)

Abstract:

8.

Studies on the Frequency of Clostridium Difficile Infections and Their Resistance, as well as Susceptibility to Different Antibiotics at King Abdulaziz Hospital in Al-Ahsaa Using Molecular Biological Methods

Number of pages: 18 Posted: 31 May 2024

Fahad AlSaab, Nawaf Alanzazi, A. Mughaith, Maha Alomari, R. Alkhalifa, E. Alsaad, G. Alsuruj, S. Alalawiy, Sarah Al-Mukhaylid and Dr. Zafar Iqbal

King Abdulaziz Hospital, King Abdulaziz Hospital, King Abdulaziz Hospital, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs, King Abdulaziz Hospital, King Abdulaziz Hospital, King Abdulaziz Hospital, King Abdulaziz Hospital, King Saud Bin Abdulaziz University for Health Sciences College of Applied Medical Sciences Ministry of National Guard Health Affairs and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs

Downloads 41 (1,196,171)

Abstract:

9.

Next-generation DNA sequences identifies mutated FANCD2 Gene as a novel Biomarker for early disease progression in Chronic Myeloid Leukemia patients

Number of pages: 20 Posted: 19 Dec 2023

Nawaf Alanzazi, Abdulaziz Siyal, Muhammad Absar, Amer Mahmood, Masood Shammas, Sarah AlMukhaylid and Dr. Zafar Iqbal

King Abdulaziz Hospital, King Saud University - Cancer Stem Cell Group, King Abdulaziz Hospital, King Saud University - Cancer Stem Cell Group, Department of Medical Oncology, Harvard (Dana Farber) Cancer Institute, King Saud Bin Abdulaziz University for Health Sciences and King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs

Downloads 26 (1,385,945)

Dr. Zafar Iqbal

King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs

Prof. Dr.

Hematology, Oncology and Genetic Engineering Sciences Research Group (H.O.P.E.S), Department of Zoology, University of the Punjab, Lahore, Pakistan.

Qarshi University

H.O.P.E.S. Research Group, Next Generation Medical Biotechnology Division, Department of Biology, Qarshi University, Lahore, Pakistan.

H.O.P.E.S Research Group & DNA Core Facility, Centre for Applied Molecular Biology, University of the Punjab

King Abdullah International Medical Research Centre (KAIMRC)

King Abdulaziz Medical City

Saudi Society for Blood and Bone Marrow Transplantation (SSBMT), National Guard Health Affairs (NGHA

9

644

1

Scholarly Papers (9)

Abstract:

Investigations on drug targetable gene mutations in blast crisis chronic myeloid leukemia and their possible implication in drug repurposing for drug-resistant advanced phase CML

Abstract:

Rare Pediatric Hematological and Non-hematological Diseases in Saudi Arabia: A Systematic Review and Meta-Analysis

Abstract:

Yaqob Taleb. An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID-19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management Strategies

Abstract:

Metabolic and Nutritional Mutation Signatures Drive Early Progression of Chronic Myeloid Leukemia: A Whole-Exome and AI-Guided Precision Framework

Abstract:

Utilization of targeted resequencing for clinical validation of mutated FANCD2 gene as a promising molecular biomarker of early disease progression in Saudi Chronic Myeloid Leukemia: A case-control study

Abstract:

Investigations on Comparative Effectiveness of Online Teaching for Delivery of Typical Health Sciences Program Curriculum, In Relation to Intended Learning Outcomes and Student Satisfaction

Abstract:

Studies on the Frequency of Clostridium Difficile Infections and Their Resistance, as well as Susceptibility to Different Antibiotics at King Abdulaziz Hospital in Al-Ahsaa Using Molecular Biological Methods

Abstract:

Next-generation DNA sequences identifies mutated FANCD2 Gene as a novel Biomarker for early disease progression in Chronic Myeloid Leukemia patients

Abstract: